J- REVERSE: sirolimus-eluting vs. everolimus-eluting stent in bifurcation lesions

Asymmetrical expansion of the stent produces an uneven neointimal growth and increases the risk of thrombosis. The study was divided into two parts: the first one aimed at comparing, in the acute phase and the medium term, the result of provisional bifurcation stenting technique with sirolimus-eluting stent vs everolimus-eluting stent (both guided by IVUS); the second one aimed at investigating whether the asymmetric expansion can cause re-endothelialization issues.

The study included 229 patients with bifurcation lesions, of which 239 [SIC] received the everolimus-eluting stent (Xience V/Promus), and 60 received the sirolimus-eluting stent (Cypher Select). There were no significant differences in MACE (death, myocardial infarction, revascularization, or stent thrombosis) at 9 months between the two stents. Patients who underwent the kissing balloon technique had a higher rate of side branch dissection with the subsequent need for a second stent. 

Conclusion: Both stents were similar for treating bifurcations with provisional stent technique guided by IVUS. The kissing balloon technique increases the chance of side branch dissection and stent asymmetric expansion if the main branch, but decreases side branch restenosis and increased luminal diameter of the main branch after 9 months without changing the MACE.

yoshinobu_murasato_europcr
Yoshinobu Murasato.
2013-05-23

Original title: Mid-term results of Japanese registry study in comparison between everolimus-eluting stent and sirolimus-eluting stent for the bifurcation lesion (J- REVERSE). 

More articles by this author

Coronary obstruction registry after TAVI

There is little information in the literature about the obstruction of the coronary ostia after percutaneous aortic valve implantation. 81 TAVI sites and programs...

Clinical results of TAVI in Asia

Since all the studies available in the literature were conducted in North America or Europe, the results of percutaneous aortic valve replacement in Asia...

RIPCORD study: FFR changes clinical consideration of chest pain

The objective of this study was to evaluate whether routine use of FFR in all the coronary arteries could change the strategy in stable...

Coherex Wave Crest: New device for atrial appendage closure

Appendage closure devices have emerged as an alternative to anticoagulation in fibrillated patients with a contraindication for it. The study included 63 patients with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...